Abbott Norvir

Ritonavir oral solution and capsules gain traditional approval May 26. The protease inhibitor has been marketed under an accelerated approval for HIV treatment received March 1, 1996. Abbott has stopped marketing the capsules because of manufacturing problems, but has filed an NDA for a soft-gel capsule ("The Pink Sheet" April 5, In Brief)